Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

The current state of tobacco cessation treatment

Humberto K. Choi, MD, FCCP, Jorge Ataucuri-Vargas, MD, Charlie Lin, MD and Amanda Singrey, PharmD, BCACP, CTTS
Cleveland Clinic Journal of Medicine July 2021, 88 (7) 393-404; DOI: https://doi.org/10.3949/ccjm.88a.20099
Humberto K. Choi
Department of Critical Care Medicine and Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Find this author on Cleveland Clinic
Jorge Ataucuri-Vargas
Pulmonary Critical Care Fellow, Respiratory Institute, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlie Lin
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Singrey
Department of Pharmacy, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    The Heaviness of Smoking Index

    How many cigarettes do you smoke a day?
    Score
    10 or fewer0
    11–201
    21–302
    31 or more3
    How soon after waking up do you smoke your first cigarette of the day?
    Score
    60 minutes0
    31–60 minutes1
    6–30 minutes2
    Within 5 minutes3
    Level of nicotine dependence by total score:
    0–2 = low
    3–4 = moderate
    5–6 = high
    • Based on information in reference 4.

    • View popup
    TABLE 2

    Suggested messages to use when giving advice on tobacco cessation

    Brief advice:
    “Quitting is the best way to improve your health.”
    Develop discrepancy:
    “How do you think your smoking is affecting your loved ones?”
    Express empathy:
    “Many people worry about managing without cigarettes.”
    Manage resistance:
    “You are worried about how you would manage withdrawal symptoms.”
    Personalized messages:
    “The best way to prevent lung cancer is to quit smoking.”
    “The best way to prevent another heart attack is to quit smoking.”
    Connect to resources:
    “There are many effective options. I can help you find the best effective treatment for you.”
    Support self-efficacy:
    “Would you like information about the benefits and strategies of quitting?”
    • View popup
    TABLE 3

    First-line pharmacologic options for tobacco cessation

    Drug, available dosesDosingAdministrationaCommon side effectsComments
    Nicotine patch (7 mg, 14 mg, 21 mg)≤ 10 cigarettes/day: start with nicotine patch 14 mg/day
    > 10 cigarettes/day: start with nicotine patch 21 mg/day
    Apply one patch each morning to any non-hairy, clean, dry skin on upper body or outer arm. Rotate the site daily to avoid skin irritation.
    After 6 weeks, taper to lower doses for 2-4 weeks.
    Skin irritation Insomnia Vivid dreamsConsider removing patch at bedtime in case of insomnia and vivid dreams.
    Nicotine gum (2 mg, 4 mg)Smokers wait > 30 min after waking to smoke: use 2 mg
    Smokers smoke within 30 min of waking: use 4 mg
    "Chew and park" is recommended: chew until tingling sensations occurs, then "park" until tingling disappears. Then chew again to repeat.
    Chew one piece of gum every 1-2 hours or whenever there is an urge to smoke.
    Use up to 24 pieces of gum/day per day for 6 weeks.
    Gradually reduce use over a second 6 weeks, for a total duration of 3 months.
    Mouth irritation
    Esophageal and gastric irritation
    Hiccups
    Jaw pain
    Nausea/vomiting
    Excess salivation
    Headache
    Palpitations
    Avoid acidic beverages (eg, coffee, carbonated drinks) 15 minutes before and during gum use, as they reduce nicotine absorption.
    Nicotine lozenge (2 mg, 4 mg)Smokers wait > 30 min after waking to smoke: use 2 mg
    Smokers smoke within 30 min of waking: use 4 mg
    Place lozenge in the mouth and allow it to dissolve for 30 minutes.
    Use 1 lozenge every 1-2 hours for 6 weeks.
    Maximum five lozenges every six hours or 20 lozenges per day.
    Gradually reduce number of lozenges used per day over a second 6 weeks.
    Mouth irritation
    Mouth ulcers
    Abdominal pain
    Hiccups
    Nausea/vomiting
    Diarrhea
    Headache
    Palpitations
    Do not chew lozenge.
    Avoid acidic beverages (eg, coffee, carbonated drinks) 15 minutes before and during gum use, as they reduce nicotine absorption.
    Nicotine inhaler (10 mg/cartridge)Puff into mouth as needed; use 6-16 cartridges per day (at least 6 cartridges per day for the first 3-6 weeks) for up to 12 weeksInhale deeply into back of throat or puff in short breaths.
    Maximum 16 cartridges per day.
    Gradually reduce dose over 6-12 weeks
    Mouth irritation Throat irritation CoughRequired frequent use.
    Each cartridge lasts about 20 minutes if continuously puffing.
    Inhaled nicotine may cause bronchospasm.
    Nicotine nasal spray (10 mg/mL)Use 1 spray in each nostril 1-2 times per hourMaximum of 10 sprays per hour or 80 spray per day.
    Adjust dose as needed based in response.
    Gradually reduce dose after 12 weeks.
    Side effects are common (headache, throat irritation, cough, rhinitis).
    Nasal irritation may be a reason to stop.
    Provides a more rapid rise in plasma nicotine concentration than that produced by agents absorbed via the oral mucosa.
    Bupropion SR (sustained release) (150 mg)150 mg once daily for 3 days, then increase to 150 mg twice dailyBegin at least 1-2 weeks before target quit date.
    May use longer than 12 weeks if needed for maintenance.
    Consider combination therapy, discontinuation, or alternative agent if no progress is made by seventh week.
    Insomnia
    Headache
    Dizziness
    Diaphoresis
    Weight loss
    Xerostomia
    Nausea/vomiting
    Consider lowering dose to 150 mg daily if full dose not tolerated.
    Decreases seizure threshold.
    Varenicline (0.5 mg, 1 mg)Days 1-3: 0.5mg once daily
    Days 4-7: 0.5 mg twice daily
    Day 8 and later: 1 mg twice daily
    Treatment should be continued for 12 weeks but can be extended.
    Consider dose reduction if usual dose is not tolerated.
    Insomnia
    Nausea/vomiting
    Abnormal dreams
    Headache
    Nasopharyngitis
    Xerostomia
    Varenicline does not increase the risk of depression, suicidal ideation, or cardiovascular disease.
    • ↵a Nicotine replacement therapy is recommended for 2 to 3 months after smoking cessation. However, it may be used through the period when the patient is at high risk for relapse. Some smokers may need to use nicotine replacement products indefinitely.

    • View popup
    TABLE 4

    Drug interactions to consider in tobacco cessation treatment

    AgentPotential drug interactions
    Nicotine replacement therapiesAdenosine, cimetidine, varenicline
    VareniclineAlcohol, nicotine, OCT2 inhibitors (eg, histamine-2-receptor blockers, quinolones, tafenoquine, trimethoprim)
    BupropionDrugs that lower seizure threshold (eg, alcohol, selective serotonin reuptake inhibitors, tricyclic antidepressants, systemic steroids)
    CYP2D6 substrates (eg, aripiprazole, atomoxetine, brexpiprazole, clozapine, codeine, duloxetine, fesoterodine, galantamine, hydrocodone, iloperidone, metoprolol, metoclopramide, nebivolol, pimozide, primaquine, selective serotonin reuptake inhibitors, tamoxifen, tamsulosin, thioridazine, tramadol, tricyclic antidepressants, valbenazine, vortioxetine)
    Dopaminergic medications (eg, amantadine, levodopa)
    CYP2B6 inducers (eg, carbamazepine, efavirenz, nelfinavir, nevirapine, phenobarbital, phenytoin, primidone, rifampin, ritonavir)
    CYP2B6 inhibitors (eg, clopidogrel, mifepristone; ticlopidine)
    Digoxin, monoamine oxidase inhibitors
    Cigarette smokeCYP1A2 substrates (eg, clozapine, fluvoxamine, olanzapine, tacrine, theophylline)
    • OCT2 = organic cation transporter 2

    • Based on information in references 24, 43, and 49.

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 88 (7)
Cleveland Clinic Journal of Medicine
Vol. 88, Issue 7
1 Jul 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The current state of tobacco cessation treatment
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The current state of tobacco cessation treatment
Humberto K. Choi, Jorge Ataucuri-Vargas, Charlie Lin, Amanda Singrey
Cleveland Clinic Journal of Medicine Jul 2021, 88 (7) 393-404; DOI: 10.3949/ccjm.88a.20099

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The current state of tobacco cessation treatment
Humberto K. Choi, Jorge Ataucuri-Vargas, Charlie Lin, Amanda Singrey
Cleveland Clinic Journal of Medicine Jul 2021, 88 (7) 393-404; DOI: 10.3949/ccjm.88a.20099
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • A PROACTIVE APPROACH TO TOBACCO CESSATION
    • EVALUATION OF NICOTINE DEPENDENCE
    • BEHAVIORAL INTERVENTIONS
    • FIRST-LINE THERAPEUTICS
    • SECOND-LINE THERAPEUTICS
    • DRUG INTERACTIONS
    • OTHER INTERVENTIONS
    • OPPORTUNITIES TO ENCOURAGE TOBACCO CESSATION
    • ELECTRONIC CIGARETTES
    • THE BOTTOM LINE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-output heart failure from arteriovenous dialysis access: A structured approach to diagnosis and management
  • Direct oral anticoagulants: Challenging prescribing scenarios in everyday practice
  • IgA nephropathy: Update on pathogenesis and treatment
Show more Review

Similar Articles

Subjects

  • Adolescent Medicine
  • Cardiology
  • Critical Care
  • Drug Therapy
  • Mental Health
  • Vascular Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire